X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE WYETH LTD TTK HEALTHCARE/
WYETH LTD
 
P/E (TTM) x 32.9 27.7 118.8% View Chart
P/BV x 6.1 5.3 113.4% View Chart
Dividend Yield % 0.5 1.3 37.6%  

Financials

 TTK HEALTHCARE   WYETH LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
WYETH LTD
Mar-13
TTK HEALTHCARE/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6631,044 63.5%   
Low Rs399818 48.8%   
Sales per share (Unadj.) Rs535.6298.6 179.4%  
Earnings per share (Unadj.) Rs15.957.2 27.9%  
Cash flow per share (Unadj.) Rs20.058.4 34.3%  
Dividends per share (Unadj.) Rs4.0017.00 23.5%  
Dividend yield (eoy) %0.81.8 41.2%  
Book value per share (Unadj.) Rs137.6249.5 55.2%  
Shares outstanding (eoy) m7.7722.72 34.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.1 31.8%   
Avg P/E ratio x33.316.3 204.8%  
P/CF ratio (eoy) x26.515.9 166.4%  
Price / Book Value ratio x3.93.7 103.4%  
Dividend payout %25.129.7 84.5%   
Avg Mkt Cap Rs m4,12721,157 19.5%   
No. of employees `0001.70.5 347.2%   
Total wages/salary Rs m607400 151.7%   
Avg. sales/employee Rs Th2,436.713,787.4 17.7%   
Avg. wages/employee Rs Th355.2813.0 43.7%   
Avg. net profit/employee Rs Th72.52,643.3 2.7%   
INCOME DATA
Net Sales Rs m4,1626,783 61.4%  
Other income Rs m61353 17.4%   
Total revenues Rs m4,2237,136 59.2%   
Gross profit Rs m1971,617 12.2%  
Depreciation Rs m3227 119.2%   
Interest Rs m306 543.6%   
Profit before tax Rs m1971,938 10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m73632 11.5%   
Profit after tax Rs m1241,301 9.5%  
Gross profit margin %4.723.8 19.9%  
Effective tax rate %37.032.6 113.4%   
Net profit margin %3.019.2 15.5%  
BALANCE SHEET DATA
Current assets Rs m1,6296,984 23.3%   
Current liabilities Rs m1,0582,056 51.5%   
Net working cap to sales %13.772.6 18.9%  
Current ratio x1.53.4 45.3%  
Inventory Days Days3099 30.0%  
Debtors Days Days3424 140.3%  
Net fixed assets Rs m556244 227.7%   
Share capital Rs m78227 34.2%   
"Free" reserves Rs m8785,441 16.1%   
Net worth Rs m1,0695,668 18.9%   
Long term debt Rs m15925 634.8%   
Total assets Rs m2,3997,901 30.4%  
Interest coverage x7.6353.3 2.1%   
Debt to equity ratio x0.10 3,364.9%  
Sales to assets ratio x1.70.9 202.0%   
Return on assets %6.416.5 38.8%  
Return on equity %11.622.9 50.5%  
Return on capital %18.534.0 54.2%  
Exports to sales %0.80.2 362.3%   
Imports to sales %1.436.3 3.9%   
Exports (fob) Rs m3315 222.3%   
Imports (cif) Rs m582,465 2.4%   
Fx inflow Rs m3315 216.4%   
Fx outflow Rs m632,677 2.4%   
Net fx Rs m-30-2,662 1.1%   
CASH FLOW
From Operations Rs m127923 13.7%  
From Investments Rs m-146317 -46.1%  
From Financial Activity Rs m22-481 -4.6%  
Net Cashflow Rs m3759 0.3%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 3.7 11.3 32.7%  
FIIs % 5.2 7.2 72.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 30.4 84.9%  
Shareholders   12,723 21,978 57.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ASTRAZENECA PHARMA  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SUN PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS